Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shennong Analgesic Plaster (神农镇痛膏) is a traditional Chinese medicine (TCM) topical medication developed and manufactured by Guangdong Zhanjiang Jimin Pharmaceutical. It is an approved over-the-counter (OTC) plaster used primarily for the relief of pain associated with rheumatism, joint pain, muscle aches, and sprains. The formulation typically combines various herbal extracts, such as Panax notoginseng, with aromatic compounds like menthol, camphor, and borneol. These ingredients work synergistically to promote local blood circulation, reduce inflammation, and provide a cooling or warming sensation that distracts from underlying pain. As a topical plaster, it allows for the sustained release of active components directly to the affected area, minimizing systemic side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shennong Analgesic Plaster.